While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

With weight loss drugs like metformin and Ozempic gaining popularity, it's essential to understand how they compare. So we had a doctor weigh in on their effectiveness, cost and side effects to help ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

It is aimed at those with type 2 diabetes. How is it taken? Unlike Ozempic and Wegovy, Rybelsus is taken in the form of a tablet, once a day. Diabetes UK recommends taking it with an empty stomach, ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...

It also costs next to nothing: £9.90 for 28 film-coated tablets in local pharmacies, amounting to two weeks' worth of treatment. Varenicline is the upgraded version of an old pill by Pfizer sold ...

Novo Nordisk stock falls as Medicare selects its marketed semaglutide medicines catering to T2D and obesity for price negotiations in 2025.

Still life of Ozempic and Wegovy ... % are tracking their health statistics “using an app on your smartphone or tablet,” also up from 19% in 2019. And what about the new weight loss drugs?